Concepedia

Publication | Open Access

Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 Year

DOIFull Paper Access

39

Citations

9

References

2016

Year

Peter G. Gibson, Brian G. Feagan, William J. Sandborn, Colleen Marano, Jewel Johanns, Lakshmi Padgett, Judith Collins, Dino Tarabar, Zbigniew Hebzda, Paul Rutgeerts,
Clinical and Translational Gastroenterology

Abstract

Subcutaneous golimumab q4w through 2 years maintained clinical benefit and reduced corticosteroid use among patients who did well in the maintenance study. No new safety signals were observed.

References

YearCitations

Page 1